CNMD
CONMED CorpCompany with tickers: CNMD
CIK
816956
CUSIP
207410101
Shares Outstanding
30,109,194
13F Activity (30d)
164 filings
141 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $1,374,724,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Revenue (ASC 606) | $1,374,724,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Cost of Revenue | — | ||||
| Gross Profit | $750,475,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Operating Expenses | $647,853,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Research & Development | $55,884,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Operating Income | $102,622,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| Net Income | $47,055,000 | USD | 2025-12-31 | 10-K | 2026-02-17 |
| EPS (Basic) | $1.52 | USD/shares | 2025-12-31 | 10-K | 2026-02-17 |
| EPS (Diluted) | $1.51 | USD/shares | 2025-12-31 | 10-K | 2026-02-17 |